$RAPP
Rapport Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
RAPP chart
What traders are saying about $RAPP
Latest postsRapport Therapeutics, Inc. news
- Guggenheim Initiates Rapport Therapeutics at Buy With $65 Price Target
Moomoo ·
- Rapport Therapeutics (RAPP) Could Be 65% Below Fair Value Following Phase 2 Trial Win
Simply Wall St ·
- Wells Fargo Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $47
Moomoo ·
- UBS maintains Rapport Therapeutics at Buy, lowers price target to $64 from $71
TradingView ·
- UBS Adjusts Rapport Therapeutics Price Target to $64 From $71, Maintains Buy Rating
marketscreener.com ·
- Guggenheim maintains Rapport Therapeutics at Buy, lowers price target to $66 from $70
TradingView ·
- Wells Fargo maintains Rapport Therapeutics at Overweight, lowers price target to $47 from $50
TradingView ·
- Wells Fargo cuts Rapport Therapeutics stock price target on safety concerns
Investing.com ·
- Rapport Therapeutics Reports Q3 2026 Net Loss of $40.2 Million
Gotrade ·
- Rapport Therapeutics (RAPP) Ticks Up 1.93% to $25.93 as Buyers Hold Above Key Support - Sell Signal Alerts
https://www.dars.gov.et/ ·
- Form 4 Rapport Therapeutics Inc: Third Rock Ventures V, L.P. (Director, 10% Owner) For: 30 October
Investing.com Nigeria ·
- Stifel reiterates Rapport Therapeutics stock rating on epilepsy focus
Investing.com ·
Rapport Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$111.5M | -$78.3M | -$34.8M |
| Diluted EPS | $-2.86 | $-3.78 | $-23.10 |
| Total assets (year end) | $512.4M | $314.9M | $155.4M |
| Cash and equivalents (year end) | $52.6M | $56.8M | $70.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Rapport Therapeutics, Inc.
- Ticker
- RAPP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 2012593
- Former names
- Rapport Therapeutics, Inc.
Frequently asked questions
What exchange is Rapport Therapeutics, Inc. listed on?
Rapport Therapeutics, Inc. trades on the Nasdaq under the ticker symbol RAPP.
What industry is Rapport Therapeutics, Inc. in?
Rapport Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Rapport Therapeutics, Inc. headquartered?
Rapport Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Rapport Therapeutics, Inc.'s fiscal year end?
Rapport Therapeutics, Inc.'s fiscal year ends on December 31.